Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor- β Signaling

Adv Exp Med Biol. 2021;1348:161-184. doi: 10.1007/978-3-030-80614-9_7.ABSTRACTMarfan Syndrome (MFS) and Loeys-Dietz Syndrome (LDS) represent heritable connective tissue disorders that segregate with a similar pattern of cardiovascular defects (thoracic aortic aneurysm, mitral valve prolapse/regurgitation, and aortic dilatation with regurgitation). This pattern of cardiovascular defects appears to be expressed along a spectrum of severity in many heritable connective tissue disorders and raises suspicion of a relationship between the normal development of connective tissues and the cardiovascular system. With overwhelming evidence of the involvement of aberrant Transforming Growth Factor-beta (TGF-β) signaling in MFS and LDS, this signaling pathway may represent the common link in the relationship between connective tissue disorders and their associated cardiovascular complications. To further explore this hypothetical link, this chapter will review the TGF-β signaling pathway, the heritable connective tissue syndromes related to aberrant TGF-β signaling, and will discuss the pathogenic contribution of TGF-β to these syndromes with a primary focus on the cardiovascular system.PMID:34807419 | DOI:10.1007/978-3-030-80614-9_7
Source: Advances in Experimental Medicine and Biology - Category: Research Authors: Source Type: research